Süss MicroTec's Record Order Book Meets a Manufacturing Shake-Up
Published on 10/28/2026 at 14:01 | Editorial boerse-global.de
Süss MicroTec has a demand problem in reverse: more business than it can currently handle. That paradox sits at the heart of a turbulent week for the semiconductor equipment maker, which trimmed its 2026 guidance and unveiled a production overhaul — then watched its shares swing sharply in both directions.
The stock fell 5.8% on the day the downgrade and relocation plans were announced, only to rebound 7.1% in the following session as analysts rushed to reframe the shortfall as a timing issue rather than a loss of business.
Guidance Cut Lands on Revenue as Well as Margins
In an ad-hoc release, Süss said it now expects 2026 revenue of EUR 405 million to EUR 425 million, down from a previous range of EUR 425 million to EUR 485 million. The new top end matches the old floor — a striking reset for a company whose order intake continues to set records.
Profitability takes a similar hit. The EBIT margin is now guided to 5% to 7%, compared with 8% to 10% previously. Roughly EUR 6.2 million in one-off charges account for a major slice of the burden, alongside temporary relocation effects and shortages of certain components.
Should investors sell immediately? Or is it worth buying Süss MicroTec?
Separately, the company reported continued strong order intake in the third quarter and a fresh all-time high for its order book. Demand, in other words, is not the issue.
Garching Production to End as Network Shifts East
Süss plans to move manufacturing out of Garching, redistributing the work to Zhubei in Taiwan and to Sternenfels. Production at the Garching site will cease entirely, affecting around 70 employees. Management frames the restructuring as a way to align its production network with future growth — but the transition costs are landing squarely on the current fiscal year.
Three Banks, One Message: Buy, but Lower Your Sights
Deutsche Bank Research cut its price target to EUR 94 from EUR 100 while keeping its buy rating. Analyst Michael Kuhn described the guidance reduction as "born of strength," arguing that overwhelming demand is forcing Süss to expand capacity faster than planned. With the order backlog preventing high demand from converting into revenue immediately, he sees solid recovery potential after the sharp share-price correction.
Berenberg followed suit, lowering its target to EUR 100 from EUR 125. Analyst Amelie Dueckelmann-Dublany pointed to capacity constraints, component shortages and one-time relocation costs, judging these burdens temporary given the record backlog. She expects strong revenue and margin growth to return from 2027.
Jefferies, meanwhile, left both its buy rating and its EUR 109 target untouched. Analyst Janardan Menon called the reduced revenue and margin targets disappointing and flagged uncertainty over revenue pushed into 2027.
Süss MicroTec at a turning point? This analysis reveals what investors need to know now.
The Question That Matters: Deferred or Lost?
The split between the banks' verdicts and their reduced targets is not a contradiction so much as a shift in emphasis. A buy rating paired with a lower target reflects operational strain without abandoning faith in the longer-term trajectory.
The critical distinction for investors is whether business is merely delayed or gone for good. Demand for mask aligners is running ahead of capacity, and Süss does not expect to lose orders. Deferred revenue can be recovered later; component scarcity and extra costs still bite in the meantime. A full order book, on its own, resolves neither.
What would settle the debate is execution — turning that backlog into revenue and margins while completing the manufacturing reshuffle. The next hard data point arrives on 5 November 2026, when Süss publishes its quarterly statement for the period ending 30 September 2026. Until then, the market is left weighing a record pipeline against a production base in the middle of being rebuilt.
Ad
Süss MicroTec Stock: New Analysis - 28 October
Fresh Süss MicroTec information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
